Free Trial
→ Forget NVDA. Put $1,000 into this stock now (From Chaikin Analytics) (Ad)tc pixel Free CORBF Stock Alerts

Global Cord Blood (CORBF) Competitors

$1.00 +0.10 (+11.11%)
As of 10:20 AM Eastern
Compare

CORBF vs. AUNA, TALK, PSNL, SBC, AIRS, EHAB, TOI, LFMD, VMD, and XGN

Should you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Auna (AUNA), Talkspace (TALK), Personalis (PSNL), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), Enhabit (EHAB), Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), and Exagen (XGN). These companies are all part of the "healthcare" industry.

Global Cord Blood vs. Its Competitors

Global Cord Blood (NYSE:CORBF) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Global Cord Blood has higher earnings, but lower revenue than Auna.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$196.12M0.62$79.04MN/AN/A
Auna$1.17B0.40$29.39M$0.887.18

In the previous week, Global Cord Blood's average media sentiment score of 0.00 beat Auna's score of -1.34 indicating that Global Cord Blood is being referred to more favorably in the media.

Company Overall Sentiment
Global Cord Blood Neutral
Auna Negative

Global Cord Blood has a beta of -0.6, meaning that its share price is 160% less volatile than the S&P 500. Comparatively, Auna has a beta of 2.26, meaning that its share price is 126% more volatile than the S&P 500.

Auna has a net margin of 5.49% compared to Global Cord Blood's net margin of 0.00%. Auna's return on equity of 15.14% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
Auna 5.49%15.14%3.60%

Auna has a consensus price target of $10.70, indicating a potential upside of 69.30%. Given Auna's stronger consensus rating and higher probable upside, analysts clearly believe Auna is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Auna
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Auna beats Global Cord Blood on 8 of the 11 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CORBF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CORBF vs. The Competition

Export to Excel
MetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$121.55M$90.14M$5.79B$21.49B
Dividend YieldN/AN/A5.69%3.53%
P/E RatioN/A0.8274.5929.70
Price / Sales0.620.44449.5451.73
Price / Cash1.402.8037.0824.52
Price / BookN/A0.1712.154.58
Net Income$79.04M$43.11M$3.28B$1.00B
7 Day PerformanceN/A-4.32%0.98%0.66%
1 Month Performance81.82%14.05%7.20%4.64%
1 Year Performance-42.86%14.95%63.06%15.96%

Global Cord Blood Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CORBF
Global Cord Blood
N/A$1.00
+11.1%		N/A-40.0%$121.55M$196.12M0.001,200Gap Down
AUNA
Auna
3.7507 of 5 stars		$6.33
+0.6%		$10.70
+69.2%		-9.3%$465.54M$1.17B7.1914,842Negative News
High Trading Volume
TALK
Talkspace
4.1014 of 5 stars		$2.65
-0.4%		$4.50
+69.8%		+43.6%$445.46M$187.59M132.57500Positive News
PSNL
Personalis
4.0113 of 5 stars		$4.81
-1.6%		$7.42
+54.2%		+2.5%$433.63M$84.61M-3.76400News Coverage
SBC
SBC Medical Group
2.0813 of 5 stars		$4.06
-0.5%		N/AN/A$423.83M$205.42M12.69N/APositive News
AIRS
AirSculpt Technologies
0.6634 of 5 stars		$6.28
-2.6%		$3.75
-40.3%		+69.6%$402.72M$180.35M-25.12240Positive News
EHAB
Enhabit
3.1388 of 5 stars		$7.86
-0.3%		$8.67
+10.3%		+1.3%$399.44M$1.03B-2.9410,700Positive News
TOI
Oncology Institute
2.601 of 5 stars		$3.25
-4.4%		$7.00
+115.4%		+999.5%$317.92M$393.41M-4.78660
LFMD
LifeMD
3.4473 of 5 stars		$6.17
-0.3%		$13.17
+113.4%		+11.6%$293.51M$212.45M-29.38230Trending News
Insider Trade
VMD
Viemed Healthcare
2.4049 of 5 stars		$6.81
-7.6%		N/A-5.9%$285.85M$224.26M20.031,179Positive News
XGN
Exagen
4.5848 of 5 stars		$9.61
-2.5%		$11.25
+17.1%		+230.0%$216.96M$55.64M-10.80220News Coverage
Analyst Upgrade

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:CORBF) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Do NOT Day Trade (Do THIS instead)
Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...
Monument Traders Alliance | Sponsoredtc pixel